Sponsor Confidential Information. If, in the performance of the Research, the Principal Investigator and members of the MIT research team designated by him/her affirmatively accept access offered by Sponsor to certain information that Sponsor considers confidential, the rights and obligations of the Parties with respect to such information are as follows:
Sponsor Confidential Information. Sponsor holds a proprietary interest in Study materials and in any written and oral information that Sponsor discloses to PPD under this Agreement. Sponsor considers all such materials and information supplied to PPD by Sponsor, or generated by PPD under this Agreement to be confidential information of Sponsor (“Sponsor Confidential Information”). As used herein, the Sponsor Confidential Information shall also include the Deliverables, Sponsor Inventions, and any other data, methods, results, conclusions, information and/or other deliverables made, conceived, reduced to practice or otherwise generated in connection with this Agreement, whether by Sponsor or PPD. PPD shall treat all Sponsor Confidential Information as the confidential and exclusive property of Sponsor, including all tangible and intangible forms of such information.
Sponsor Confidential Information. Should it be necessary for Purdue personnel to receive Sponsor’s confidential information, Sponsor agrees to state in writing at the time of delivery that such information is confidential, or if given orally, the confidential information shall (within 30 days of the oral disclosure) be reduced to writing and clearly marked as confidential. Purdue agrees to safeguard Sponsor’s confidential information to the same extent that Purdue safeguards its own confidential information. Purdue shall, upon request of Sponsor, return Sponsor’s confidential information to Sponsor at the conclusion of the Project.
Sponsor Confidential Information. PPD shall treat all information obtained from Sponsor and all Sponsor Property (as defined below) and any revisions, improvements or enhancements thereto (“Sponsor Confidential Information”) as the confidential and exclusive property of Sponsor.
Sponsor Confidential Information. (a) The parties acknowledge that Sponsor may disclose to the Institute certain confidential and proprietary info1mation of Sponsor. Such information may take the form of, among other things: data concerning scientific discoveries made by Sponsor; Sponsor’s marketing plans; Sponsor’s strategy for or status of regulatory approval; or Sponsor’s forecasts of sales and sales data (hereafter referred to collectively as “Sponsor Confidential Information”).
Sponsor Confidential Information. PPD and any of its Affiliates or third party on its behalf shall treat all information and materials including any Project drug obtained from Sponsor or a third party on its behalf, and any Project results, data and records generated or developed during any Project, any deliverable under a Project Addendum and any Sponsor’s Property (as defined below) (“Sponsor Confidential Information”) as the confidential and exclusive property of Sponsor. In addition, any of PPD’s Affiliates or third parties performing on PPD’s behalf receiving information from Sponsor or any Sponsor’s affiliate shall be bound by the confidentiality obligations. Portions of this exhibit have been omitted and filed separately with the SEC pursuant to a confidential treatment request and are indicated by ***. PPD PROPRIETARY AND CONFIDENTIAL
Sponsor Confidential Information a. Sponsor may disclose confidential information to PRA during the course of this Agreement. All information provided by or on behalf of Sponsor or data collected by PRA during the performance of the Services is deemed to be the confidential information of Sponsor and is hereinafter referred to as “Sponsor Information”. PRA will not disclose Sponsor Information to any person other than its employees, agents, Investigators, Trial Sites and independent contractors involved in the Services or use any such information for any purpose other than the performance of Services without the prior written consent of Sponsor.
Sponsor Confidential Information. “Sponsor Confidential Information” means (a) any and all scientific, technical, business, regulatory, or financial information in whatever form (written, oral, electronic or visual) that is delivered or otherwise disclosed to HJF, CRO, RedHill, Sites, Site Principal Investigators, or Principal Investigator (“Recipient”), by or on behalf of HJF or RedHill or its designees (“Discloser”) for the purpose of conducting the Study, including the Protocol, the financial terms of this Agreement; (b) all approvals and correspondence with or from an IRB or other entities with oversight responsibilities for the Study, including ethics committees or data safety monitoring committees, all Study correspondence, all Study Drug accountability forms, and all CRFs (collectively, the “Study Documentation”); (c) all Study Data and (d) information that a reasonable person familiar with the Study would consider to be confidential or proprietary from the context or circumstances of disclosure; provided, however, that (i) Study Drug Sponsor and HJF are co-exclusive owners of all Study Data pursuant to Section 9.2 (Study Data and Materials) and are free to use their own Confidential Information subject to Section 7 (Publication); (ii) Protocol Principal Investigator may use and/or publish Study Data solely in accordance with this Agreement; (iii) Sites and Site Principal Investigators may use and/or publish Study Data solely in accordance with the applicable Site contract, substantially similar to those terms and conditions applicable to the Parties under this Agreement; (iv) the U.S. Government may use and/or publish Study Data and Technical Data in accordance with the OTA; and (v) a Discloser is free to use its own Sponsor Confidential Information for which it is the Discloser.
Sponsor Confidential Information. Should it be necessary for Auburn personnel to receive Sponsor confidential Information, Sponsor agrees to state in writing at the time of delivery that such information is confidential, or if given orally, reduced to writing, clearly marked as confidential, within 30 days of the oral disclosure. Auburn and its personnel agree to safeguard Sponsor confidential material to the same extent it safeguards its own.
Sponsor Confidential Information a. Sponsor may disclose confidential information to PRA during the course of this Agreement. All information provided by or on behalf of Sponsor (including the study drug) or Data collected by PRA during the performance of the Services, including the study results and Sponsor’s Intellectual Property are deemed to be the confidential information of Sponsor and is hereinafter referred to as “Sponsor Information”. PRA will not disclose Sponsor Information to any person other than its employees, agents, Investigators, Trial Sites, regulatory authorities, IRBs (only to the extent required by applicable law) and Subcontractors involved in the Services to whom it needs to disclose such specific information or use any such information for any purpose other than the performance of Services without the prior written consent of Sponsor.
